The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. The organic electroluminescent device having improved driving voltage and/or current efficiency characteristics can be provided by comprising the organic electroluminescent compound according to the present disclosure.

To provide an organic electroluminescent device in which energy efficiency is improved. An organic electroluminescent device includes a pair of electrode layers formed of an anode layer and a cathode layer, and a luminescent layer arranged between the pair of electrode layers, in which the luminescent layer includes a host material and a dopant material, and the dopant material is an anthracene-based compound represented by formula (1), and the luminescent layer further includes a polycyclic aromatic compound represented by formula (2) or a multimer of a polycyclic aromatic compound having a plurality of structures represented by formula (2). ##STR00001##

A composition for manufacturing an organic electronic device includes at least three organic functional materials H1, H2, and H3, and at least one organic solvent. The organic functional materials H1 and H2 can form a type II semiconductor heterojunction structure. A LUMO value of the organic functional material H3 is greater than or equal to that of the organic functional materials H1 and H2, and a HOMO value thereof is less than or equal to that of the organic functional materials H1 and H2.

The present invention provides compounds isolated from avocado seeds for use as a natural colorant in edible materials. The compounds of the invention are useful for coloring edible materials red, orange, or yellow. The invention also provides compositions and methods for coloring edible materials to a desired color such as red, orange, or yellow.

This present disclosure relates to protein kinase C (PKC) modulating compounds, methods of treating a subject with cancer using the compounds, and combination treatments with a second therapeutic agent.

An organic electroluminescence device including: a cathode; an anode; and at least one emitting layer disposed between the cathode and the anode, wherein the emitting layer contains a first host material, a second host material, and a dopant material, wherein the first host material is a compound represented by the following formula (1), the second host material is a compound represented by the following formula (2), and the first host material and the second host material are different compounds.

##STR00001##

An object of the present invention is to provide an organic electroluminescent element having optimal light emitting characteristics. The above problem is solved by an organic electroluminescent element having a light emitting layer containing a compound of formula (1) or a multimer compound having a plurality of structures of formula (1) and a compound of formula (2).

##STR00001##

(In formula (1), ring A, ring B, and ring C each represent an aryl ring or the like, X.sup.1 and X.sup.2 each independently represent O or N—R, and the R represents an aryl or the like. In formula (2), R.sup.1 to R.sup.10 each represent an aryl or the like.)

Provided is a compound of Chemical Formula 1: ##STR00001## where R.sub.1 and R.sub.2 are each independently hydrogen, a substituted or unsubstituted C.sub.1-60 alkyl, a substituted or unsubstituted C.sub.1-60 alkoxy, a substituted or unsubstituted C.sub.1-60 haloalkyl, a substituted or unsubstituted C.sub.1-60 haloalkoxy, halogen, cyano, tri(C.sub.1-60 alkyl)silyl, a substituted or unsubstituted C.sub.6-60 aryl, or a substituted or unsubstituted C.sub.2-60 heteroaryl containing at least one of O, N, Si and S, R.sub.3 and R.sub.4 are each independently hydrogen, deuterium, a substituted or unsubstituted C.sub.1-60 alkyl, a substituted or unsubstituted C.sub.1-60 alkoxy, a substituted or unsubstituted C.sub.1-60 haloalkyl, a substituted or unsubstituted C.sub.1-60 haloalkoxy, halogen, cyano, tri(C.sub.1-60 alkyl)silyl, or a substituted or unsubstituted C.sub.2-60 heteroaryl containing at least one of O, N, Si and S, and Ar is C.sub.6-60 aryl, or C.sub.2-60 heteroaryl containing at least one of O, N, Si and S, wherein the C.sub.6-60 aryl, or C.sub.2-60 heteroaryl is substituted with 1 to 5 substituents each selected from the group consisting of a substituted or unsubstituted C.sub.1-60 alkyl, a substituted or unsubstituted C.sub.1-60 alkoxy, a substituted or unsubstituted C.sub.1-60 haloalkyl, a substituted or unsubstituted C.sub.1-60 haloalkoxy, halogen, cyano, and tri(C.sub.1-60 alkyl)silyl, and an organic light emitting device including the same.

An organic EL device includes a first emitting layer and a second emitting layer, in which the first emitting layer contains a first host material, the second emitting layer contains a second host material, the first and the second host material are mutually different, the first emitting layer and the second emitting layer at least contains a compound that emits fluorescence having a main peak wavelength of 500 nm or less, respectively, the compound contained in the first emitting layer and that emits fluorescence having a main peak wavelength of 500 nm or less is the same as or different from the compound contained in the second emitting layer, and a triplet energy T.sub.1(H1) of the first host material and a triplet energy T.sub.1(H2) of the second host material satisfy a numerical formula (Numerical Formula 1),

T.sub.1(H1)>T.sub.1(H2)  (Numerical Formula 1).

Provided herein is a compound of Formula (1-I): or a pharmaceutically acceptable salt thereof, wherein R.sup.2a, R.sup.2b, R.sup.3, R.sup.4a, R.sup.4b, R.sup.5, R.sup.6a, R.sup.6b, R.sup.11a, R.sup.11b, R.sup.16a, R.sup.16b, R.sup.19, R.sup.18, X, q, r, s, t, u, and n are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (1-I) and methods of using the compounds, e.g, in the treatment of CNS-related disorders.

##STR00001##